Gerard Brophy - Mar 1, 2022 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Biopharma Production
Signature
/s/ Scott Baker, as Attorney-in-Fact
Stock symbol
AVTR
Transactions as of
Mar 1, 2022
Transactions value $
-$69,871
Form type
4
Date filed
3/2/2022, 04:07 PM
Previous filing
Feb 25, 2022
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Sale -$69.9K -2.03K -1.47% $34.47 136K Mar 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.